VBI VACCINES INC.

VBIV
Delayed Quote. Delayed  - 06/24 04:00:00 pm
3.95USD +1.28%

VBI Vaccines : Partners Commence Phase 2 Clinical Trial of BRII-835 in Combination with BRII-179 for Treating Hepatitis B

04/21/2021 | 09:30am
MarketScreener.com
This article is reserved for subscribers
A "one-stop shopping" service for investors
The best opportunities, portfolios, and screeners
Discover